Manufacturing: Page 9
-
PharmaVoice Team/PharmaVoice
Navigating New Channels
6 March 2009 VIEW on Advertising THE FORUM Marketers across the board — from sponsor companies to healthcare agencies — are having to accomplish more with fewer resources while finding new ways to address target audiences. “As an industry, we are being asked to do more with less,” says Barry Lee,...
By PharmaVoice Team • March 15, 2009 -
PharmaVoice Team/PharmaVoice
Trials and Tribulations
Clinical trials can provide lifesaving options for some of the more than 60 million critically ill Americans. Yet, due to recent public scrutiny, clinical trials have come under fire based on isolated incidents that have caused some to question the efficacy and safety of trials. According to the ...
By PharmaVoice Team • March 11, 2009 -
Explore the Trendline➔
Getty Images
TrendlineArtificial intelligence & machine learning
After years of excited buzz around the potential of artificial intelligence and machine learning, pharma has begun to realize the true implications and potential value of these technologies.
By PharmaVoice staff -
PharmaVoice Team/PharmaVoice
Advertising or Patient Safety?
Contributed by Frederick J. Balboni Jr., Executive Director, Consortium for the Advancement of Patient Safety (CAPS) What if all label instructions and warnings suddenly disappeared? Issue Overview In May 2010, the pharmaceutical manufacturing industry may be faced with a daunting change. The Uni...
By Frederick J. Balboni Jr • Feb. 27, 2009 -
PharmaVoice Team/PharmaVoice
Talent Pool
TALENT POOL EXECUTIVE APPOINTMENTS AND PROMOTIONS IN THE HEALTHCARE INDUSTRY Pharma POOL Lamberto ANDREOTTI Dr. Andrew G. BODNAR Donald J. HAYDEN Dr. James B. D. PALMER Thomas J. PICKARD David L. ZABOR Bristol-Myers Squibb Announces New Senior Leadership Team — Appoints Former GlaxoSmithKline V...
By PharmaVoice Team • Feb. 23, 2009 -
PharmaVoice Team/PharmaVoice
Information Technology: Tracking the E-Volution
Pharmaceutical companies have long term plans, they have products that take a long time to develop, a long time to test to gain approval, and they have a shelf life. But technology moves so much faster than that. So the industry as a whole has had to adopt to the speed of technology. IAN CROSS BY...
By PharmaVoice Team • Feb. 21, 2009 -
PharmaVoice Team/PharmaVoice
The Practice of Public Relations
When effectively managed, public relations creates unique opportunities for marketers to provide con sumers and healthcare professionals with immediate and thorough drug and healthcare information. The healthcare publicrelations market in the United States grew 30% last year and is now valued at ...
By PharmaVoice Team • Feb. 21, 2009 -
PharmaVoice Team/PharmaVoice
Letter from the Editor
PUBLISHER Lisa Banket EDITOR Taren Grom CREATIVE DIRECTOR Marah Walsh CONTRIBUTING EDITORS Diane Hoffman Virginia Kirk Denise Myshko Kim Ribbink Deborah Ruriani Copyright 2001 by PharmaLinx LLC, Titusville, NJ Printed in the U.S.A. Volume One, Number Two PharmaVoice is published six times per yea...
By Taren Grom • Feb. 12, 2009 -
PharmaVoice Team/PharmaVoice
The Green of Going Green
The pharmaceutical industry has made enormous strides to limit its impact on the environment and create projects that improve sustainability. Increasingly, this socially responsible approach also makes good business sense, as more companies are discovering. Doing good and doing well may well be s...
By PharmaVoice Team • Dec. 22, 2008 -
PharmaVoice Team/PharmaVoice
Personalized Medicine
RESEARCH & Development PERSONALIZED MEDICINE The Right Dose at the Right time BY DENISE MYSHKO Obstacles and challenges still remain to make the vision of personalized medicine a reality. Despite some early successes, the development of targeted medicines and pharmacogenomics-based testing ha...
By Denise Myshko • Nov. 22, 2008 -
PharmaVoice Team/PharmaVoice
Development
development RESEARCH & Development BY DENISE MYSHKO Models of CHANGE In the future, successful biopharmaceutical companies will be those that have reviewed R&D business models and implemented updated strategies for improving the development of new products. The pharmaceutical industry is ...
By PharmaVoice Team • Nov. 22, 2008 -
PharmaVoice Team/PharmaVoice
Counterfeit Drugs
Corporate Strategy Counterfeit Drugs Fighting an uphill battle BY DENISE MYSHKO The counterfeit medicines market is a real, clear, and present danger to public health. And while there have been efforts to minimize the threat of counterfeit and substandard medicines, there is a need to coordinate ...
By Denise Myshko • Nov. 22, 2008 -
PharmaVoice Team/PharmaVoice
The Corner Office
Corporate Strategy A review of the annual reports and public statements of more than two dozen of the industry’s publicly traded pharmaceutical/biotechnology companies reveals the top trends as identified by the CEOs, presidents, and executive management teams of these industry standard bearers. ...
By PharmaVoice Team • Nov. 22, 2008 -
PharmaVoice Team/PharmaVoice
Talent Pool
Pharma POOL Dr. Barry Goldstein Merck Appoints Head of Diabetes, Obesity Development Global pharmaceutical company Merck, Whitehouse Station, N.J., has named Barry Goldstein, M.D., Ph.D., FACP, FACE, VP of diabetes and obesity clinical development. In addition to leading overall development of co...
By PharmaVoice Team • Nov. 22, 2008 -
PharmaVoice Team/PharmaVoice
Table of Contents
Contents November/December 2008 98 PATIENT EDUCATION Product managers still need to reach patients with messages that resonate on a personal level. 102 DOCTORS’CHOICE AWARDS A review of the 2008 winners. IN EVERY ISSUE 3 Letter from the Editor 6 UpFront 104 What’s New 108 EMedia 113 OnThe Calenda...
By PharmaVoice Team • Nov. 22, 2008 -
PharmaVoice Team/PharmaVoice
Talent Pool
Pharma POOL Mark GLICKMAN Oscient Promotes Sales Executive Commercial stage pharmaceutical company Oscient Pharmaceuticals, Waltham, Mass., has promoted Mark Glickman to senior VP, sales and marketing, and corporate officer. Since joining Oscient in August 2007 as VP of sales, Mr. Glickman has be...
By PharmaVoice Team • Sept. 30, 2008 -
PharmaVoice Team/PharmaVoice
On the Calendar
October 15 3rd Leadership Summit on Medicare Enrollment and PDE Data Reconciliation Hilton Old Town, Alexandria, Va. PharmaVOICE subscribers receive $300 discount; register using keycode HYU957. For more information, contact Jodi Bova, Center for Business Intelligence, at 781-939-2563, email jodi...
By PharmaVoice Team • Sept. 30, 2008 -
PharmaVoice Team/PharmaVoice
What's New
NEW HEALTH CARE RELATED PRODUCTS, SERVICES, AND COMPANIES Julie Kampf has launched Career Central, a consulting firm that provides executive skill building to job seekers ranging from recent college graduates to senior level managers to professionals seeking a second or third career. Career Centr...
By PharmaVoice Team • Sept. 30, 2008 -
PharmaVoice Team/PharmaVoice
Marketing Inside the Lines
THE FORUM The industry has responded by drafting its own rules of conduct. In July, the Pharmaceutical Research and Manufacturers of America (PhRMA) released a revised version of its 2002 Code on Interactions with Healthcare Professionals, a set of voluntary guidelines designed to ensure the foc...
By PharmaVoice Team • Sept. 16, 2008 -
PharmaVoice Team/PharmaVoice
The Green Movement: Rethinking Chemistry
BY DENISE MYSHKO Major pharmaceutical companies are working together to minimize the environmental impact of how they make their products. The GREEN MOVEMENT Rethinking Chemistry GREEN IS THE NEW BLACK. The push to make prescription drugs more efficient, cleaner, and safer is gaining momentum ami...
By Denise Myshko • Aug. 27, 2008 -
PharmaVoice Team/PharmaVoice
What's New
WHAT’S NEW NEW HEALTH CARE RELATED PRODUCTS, SERVICES, AND COMPANIES IMS Health has joined with 10 leading U.S. academic researchers in medicine, health economics, and public health to establish the Health Services Research Network (HSRN), a consortium that will apply IMS’s evidence based informa...
By PharmaVoice Team • Aug. 27, 2008 -
PharmaVoice Team/PharmaVoice
PharmaOutlet
The words “corporate social responsibility” are flooding the headlines. While not a new concept, in today’s world there is a fundamental expectation that we should do business in an ethical manner that supports the wellbeing and betterment of society. Under constant scrutiny by industry regulator...
By William Clapper • Aug. 27, 2008 -
PharmaVoice Team/PharmaVoice
Cover
PharmaVOICE PharmaVOICE 100 THE FORUM FOR THE INDUSTRY EXECUTIVE July/August 2008 SPECIAL ISSUE 100 of the Most Inspiring People www.pharmavoice.com Download PDF
By PharmaVoice Team • July 28, 2008 -
PharmaVoice Team/PharmaVoice
Letter from the Editor
PharmaVOICE is delighted to publish the fourth annual special issue featuring 100 of the most inspiring individuals in the life-sciences industry. This issue has become one of my favorites and, from all accounts, one of yours as well. What’s not to love? This issue celebrates the men and women of...
By Taren Grom • July 27, 2008 -
PharmaVoice Team/PharmaVoice
The Mentors
Brian Corvino Mary Lacquaniti Lelia O’Connor Danita Sutton, Ph.D. MENTORING AND SHAPING THE CAREERS OF OTHERS ARE VENERABLE AND ADMIRABLE TALENTS. MENTORING TAKES PATIENCE, FORESIGHT, AND UNSELFISH DEVOTIONTO OTHERS’ SUCCESS and is a skill that is often unheralded — until now. We salute those who...
By PharmaVoice Team • July 24, 2008 -
PharmaVoice Team/PharmaVoice
The Technologists
Valdo Arnera, M.D. Bill Byrom, Ph.D. Philip A. Garland Keith Howells Don Schenker Rodney Spady A creative and passionate approach to pioneering new areas of technology applications and new products has enabled Dr. Bill Byrom to engender real improvements in the drug development process. For the p...
By PharmaVoice Team • July 24, 2008
Previous
